Výsledky vyhledávání

Zobrazeno 1 - 10 of 21 pro vyhledávání: '"Hagene KT"'

Řazení

Vybrat vše | Vybrané výsledky:

Vybrat výsledek číslo 1 1

Akademický článek

Autor: Aamdal E; Department of Oncology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Electronic address: eliaam@ous-hf.no., Skovlund E; Department of Public Health and Nursing, Norwegian University of Science and Technology, NTNU, Trondheim, Norway., Jacobsen KD; Department of Oncology, Oslo University Hospital, Oslo, Norway., Straume O; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway; Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway., Kersten C; Research Unit, Sørlandet Hospital, Kristiansand, Norway; Department of Oncology, Akershus University Hospital, Lørenskog, Norway., Herlofsen O; Department of Oncology, Ålesund Hospital, Ålesund, Norway., Karlsen J; The Cancer Clinic, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway., Hussain I; Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway., Amundsen A; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Dalhaug A; Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway., Nyakas M; Department of Oncology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Hagene KT; Department of Oncology, Oslo University Hospital, Oslo, Norway., Holmsen K; Department of Oncology, Oslo University Hospital, Oslo, Norway., Aamdal S; Department of Oncology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Kaasa S; Department of Oncology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Guren TK; Department of Oncology, Oslo University Hospital, Oslo, Norway. Electronic address: http://www.twitter.com/TormodGuren., Kyte JA; Department of Oncology, Oslo University Hospital, Oslo, Norway; Department of Cancer Immunology, Institute of Cancer Research, Oslo University Hospital, Oslo, Norway. Electronic address: http://www.twitter.com/GroupKyte.

Publikováno v: ESMO open [ESMO Open] 2022 Oct; Vol. 7 (5), pp. 100588. Date of Electronic Publication: 2022 Sep 16.

Zobrazit plný text záznamu

Vybrat výsledek číslo 2 2

Akademický článek

Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up.

Autor: Aamdal E; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Akershus University Hospital, Lørenskog, Norway., Jacobsen KD; Department of Oncology, Oslo University Hospital, Oslo, Norway., Straume O; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.; Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway., Kersten C; Research Unit, Sørlandet Hospital, Kristiansand, Norway., Herlofsen O; Department of Oncology, Ålesund Hospital, Ålesund, Norway., Karlsen J; The Cancer Clinic, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway., Hussain I; Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway., Amundsen A; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Dalhaug A; Department of Oncology and Palliative Medicine, Nordland Hospital, Norway., Nyakas M; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Schuster C; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.; Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway., Hagene KT; Department of Oncology, Oslo University Hospital, Oslo, Norway., Holmsen K; Department of Oncology, Oslo University Hospital, Oslo, Norway., Russnes HG; Department of Pathology, Oslo University Hospital, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Skovlund E; Department of Public Health and Nursing, Norwegian University of Science and Technology, NTNU, Trondheim, Norway., Kaasa S; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Aamdal S; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Kyte JA; Department of Oncology, Oslo University Hospital, Oslo, Norway., Guren TK; Department of Oncology, Oslo University Hospital, Oslo, Norway.

Publikováno v: International journal of cancer [Int J Cancer] 2022 Jan 01; Vol. 150 (1), pp. 100-111. Date of Electronic Publication: 2021 Sep 09.

Zobrazit plný text záznamu

Vybrat výsledek číslo 3 3

Akademický článek

Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma.

Autor: Nyakas M; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Aamdal E; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Jacobsen KD; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Guren TK; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Aamdal S; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Hagene KT; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Brunsvig P; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Yndestad A; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; K.G. Jebsen Inflammatory Research Center, University of Oslo, Oslo, Norway., Halvorsen B; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; K.G. Jebsen Inflammatory Research Center, University of Oslo, Oslo, Norway., Tasken KA; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Aukrust P; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; K.G. Jebsen Inflammatory Research Center, University of Oslo, Oslo, Norway.; K. G. Jebsen Thrombosis Research and Expertise Center, University of Tromsø, Tromsø, Norway., Maelandsmo GM; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; Department of Medical Biology, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway., Ueland T; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; K. G. Jebsen Thrombosis Research and Expertise Center, University of Tromsø, Tromsø, Norway.

Publikováno v: Clinical and experimental immunology [Clin Exp Immunol] 2019 Jul; Vol. 197 (1), pp. 74-82. Date of Electronic Publication: 2019 Mar 21.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Vybrat výsledek číslo 4 4

Akademický článek

Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate.

Autor: Ree AH; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Russnes HG; Department of Pathology, Oslo University Hospital, Oslo, Norway.; Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway., Heinrich D; Department of Oncology, Akershus University Hospital, Lørenskog, Norway., Dueland S; Department of Oncology, Oslo University Hospital, Oslo, Norway., Boye K; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Department of Tumor Biology, Oslo University Hospital, Oslo, Norway., Nygaard V; Department of Tumor Biology, Oslo University Hospital, Oslo, Norway., Silwal-Pandit L; Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway., Østrup O; Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway., Hovig E; Department of Tumor Biology, Oslo University Hospital, Oslo, Norway.; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway.; Institute of Computer Science, University of Oslo, Oslo, Norway.; Norwegian Cancer Genomics Consortium, Oslo, Norway., Nygaard V; Department of Core Facilities, Oslo University Hospital, Oslo, Norway., Rødland EA; Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway., Nakken S; Department of Tumor Biology, Oslo University Hospital, Oslo, Norway.; Norwegian Cancer Genomics Consortium, Oslo, Norway., Øien JT; Department of Tumor Biology, Oslo University Hospital, Oslo, Norway., Johansen C; Department of Oncology, Akershus University Hospital, Lørenskog, Norway., Bergheim IR; Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway., Skarpeteig V; Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway., Sathermugathevan M; Department of Tumor Biology, Oslo University Hospital, Oslo, Norway., Sauer T; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Pathology, Akershus University Hospital, Lørenskog, Norway., Lund-Iversen M; Department of Pathology, Oslo University Hospital, Oslo, Norway., Beiske K; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Pathology, Oslo University Hospital, Oslo, Norway., Nasser S; Department of Radiology, Akershus University Hospital, Lørenskog, Norway., Julsrud L; Department of Radiology, Oslo University Hospital, Oslo, Norway., Reisse CH; Department of Radiology, Oslo University Hospital, Oslo, Norway., Ruud EA; Department of Radiology, Akershus University Hospital, Lørenskog, Norway., Flørenes VA; Department of Pathology, Oslo University Hospital, Oslo, Norway., Hagene KT; Department of Oncology, Oslo University Hospital, Oslo, Norway., Aas E; Institute of Health & Society, University of Oslo, Oslo, Norway.; Department of Health Services Research, Akershus University Hospital, Lørenskog, Norway., Lurås H; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Health Services Research, Akershus University Hospital, Lørenskog, Norway., Johnsen-Soriano S; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.; Department of Tumor Biology, Oslo University Hospital, Oslo, Norway., Geitvik GA; Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway., Lingjærde OC; Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway.; Institute of Computer Science, University of Oslo, Oslo, Norway., Børresen-Dale AL; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Cancer Genetics, Oslo University Hospital, Oslo, Norway., Mælandsmo GM; Department of Tumor Biology, Oslo University Hospital, Oslo, Norway., Flatmark K; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Tumor Biology, Oslo University Hospital, Oslo, Norway.; Department of Gastroenterological Surgery, Oslo University Hospital, Oslo, Norway.

Publikováno v: ESMO open [ESMO Open] 2017 May 02; Vol. 2 (2), pp. e000158. Date of Electronic Publication: 2017 May 02 (Print Publication: 2017).

Zobrazit plný text záznamu

Vybrat výsledek číslo 5 5

Akademický článek

Structure-activity relationships of N-substituted ligands for the alpha7 nicotinic acetylcholine receptor.

Autor: Mortell KH; Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064, USA. kathleen.mortell@abbott.com, Schrimpf MR, Bunnelle WH, Anderson DJ, Gronlien JH, Hagene KT, Gopalakrishnan M

Publikováno v: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2010 Jan 01; Vol. 20 (1), pp. 104-7. Date of Electronic Publication: 2009 Nov 14.

Zobrazit plný text záznamu

Vybrat výsledek číslo 6 6

Akademický článek

Recent advances in immunotherapy and its combination therapies for advanced melanoma: a review.

Autor: Jiamin Xu, Shukun Mu, Yun Wang, Suchun Yu, Zhongming Wang

Publikováno v: Frontiers in Oncology; 2024, p1-11, 11p

Zobrazit plný text záznamu

Vybrat výsledek číslo 7 7

Akademický článek

Mechanismen der Immuntherapie-Resistenz bei kutanem Melanom: Erkennen eines Formwandlers.

Autor: Thornton, Jessica¹ (AUTHOR), Chhabra, Gagan¹ (AUTHOR), Singh, Chandra K.¹ (AUTHOR), Guzman-Perez, Glorimar¹ (AUTHOR), Shirley, Carl A.¹ (AUTHOR), Ahmad, Nihal^1,2 (AUTHOR)

Publikováno v: Kompass Dermatologie. Jul2022, Vol. 10 Issue 3, p107-117. 11p.